Abstract

Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder with progressive degeneration of cerebellar Purkinje cells (PCs) and other neurons caused by expansion of a glutamine (Q) tract in the ATXN2 protein. We generated BAC transgenic lines in which the full-length human ATXN2 gene was transcribed using its endogenous regulatory machinery. Mice with the ATXN2 BAC transgene with an expanded CAG repeat (BAC-Q72) developed a progressive cellular and motor phenotype, whereas BAC mice expressing wild-type human ATXN2 (BAC-Q22) were indistinguishable from control mice. Expression analysis of laser-capture microdissected (LCM) fractions and regional expression confirmed that the BAC transgene was expressed in PCs and in other neuronal groups such as granule cells (GCs) and neurons in deep cerebellar nuclei as well as in spinal cord. Transcriptome analysis by deep RNA-sequencing revealed that BAC-Q72 mice had progressive changes in steady-state levels of specific mRNAs including Rgs8, one of the earliest down-regulated transcripts in the Pcp2-ATXN2[Q127] mouse line. Consistent with LCM analysis, transcriptome changes analyzed by deep RNA-sequencing were not restricted to PCs, but were also seen in transcripts enriched in GCs such as Neurod1. BAC-Q72, but not BAC-Q22 mice had reduced Rgs8 mRNA levels and even more severely reduced steady-state protein levels. Using RNA immunoprecipitation we showed that ATXN2 interacted selectively with RGS8 mRNA. This interaction was impaired when ATXN2 harbored an expanded polyglutamine. Mutant ATXN2 also reduced RGS8 expression in an in vitro coupled translation assay when compared with equal expression of wild-type ATXN2-Q22. Reduced abundance of Rgs8 in Pcp2-ATXN2[Q127] and BAC-Q72 mice supports our observations of a hyper-excitable mGluR1-ITPR1 signaling axis in SCA2, as RGS proteins are linked to attenuating mGluR1 signaling.

Highlights

  • Spinocerebellar ataxia type 2 (SCA2) belongs to the group of neurodegenerative diseases caused by polyglutamine expansion

  • Quantitative PCR analyses of genomic DNA revealed that both bacterial artificial chromosome (BAC)-Q22 and BAC-Q72 mice had tandem integrates of 10 and 4 copies of the ATXN2 transgene, respectively

  • In RT-PCR analyses, both BAC-Q22 and BAC-Q72 mice demonstrated the expression of intact human ATXN2 transcripts throughout the central nervous system (CNS), including cerebral hemispheres, cerebellum and spinal cord (Fig 1B)

Read more

Summary

Introduction

Spinocerebellar ataxia type 2 (SCA2) belongs to the group of neurodegenerative diseases caused by polyglutamine (polyQ) expansion. In contrast to other polyQ diseases, mutant ATXN2 does not enter the nucleus in appreciable amounts in early stages of disease This is confirmed by protein interaction studies that have identified ATXN2 interactors with cytoplasmic localization [5,6,7,8]. Polyglutamine disorders show their pathology through a toxic gain of function of the protein and larger polyQ expansions have been associated with greater pathology [3,9]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call